Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation

Ischemia and reperfusion injury (IRI) is a dynamic process that involves two distinctive yet interrelated phases of ischemic organ damage and inflammation‐mediated reperfusion injury. Although multiple cellular and molecular pathways contribute and regulate tissue/organ damage, integration of different players into a unified mechanism is warranted. The crosstalk between innate and adaptive immune systems plays a significant role in the pathogenesis of liver IRI. In this review, we focus on recent progress in the mechanism of liver innate immune activation by IR. Kupffer cells (KC), DCs, NK, as well as T cells initiate local inflammation response, the hallmark of IRI, by utilizing distinctive immune receptors to recognize and/or trigger various molecules, both endogenous and exogenous. The interlocked molecular signaling pathways in the context of multiple liver cell types, the IRI kinetics and positive versus negative regulatory loops in the innate immune activation process are discussed. Better appreciation of molecular interactions that mediate these intricate cascades, should allow for the development of novel therapeutic approached against IRI in liver transplant recipients.

[1]  P. Zhu,et al.  Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. , 2011, Human gene therapy.

[2]  I. Maričić,et al.  Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. , 2011, Gastroenterology.

[3]  K. Abdi,et al.  Antigen‐Activated T Cells Induce IL‐12p75 Production from Dendritic Cells in an IFN‐γ‐Independent Manner , 2010, Scandinavian journal of immunology.

[4]  S. Robson,et al.  Transgenic Overexpression of CD39 Protects Against Renal Ischemia‐Reperfusion and Transplant Vascular Injury , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  E. Podrez,et al.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands , 2010, Nature.

[6]  P. Kubes,et al.  Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.

[7]  B. Ke,et al.  Programmed death‐1/B7‐H1 negative costimulation protects mouse liver against ischemia and reperfusion injury , 2010, Hepatology.

[8]  Xiu‐da Shen,et al.  Alloimmune Activation Enhances Innate Tissue Inflammation/Injury in a Mouse Model of Liver Ischemia/Reperfusion Injury , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  R. Schnellmann,et al.  Murine Kupffer Cells Are Protective in Total Hepatic Ischemia/Reperfusion Injury with Bowel Congestion through IL-10 , 2010, The Journal of Immunology.

[10]  D. Candinas,et al.  Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice , 2010, Hepatology.

[11]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[12]  G. Plitas,et al.  Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. , 2010, Journal of Clinical Investigation.

[13]  G. Plitas,et al.  Toll‐like receptor 9 inhibition confers protection from liver ischemia–reperfusion injury , 2010, Hepatology.

[14]  C. Leclerc,et al.  Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.

[15]  Yanghua Qin,et al.  HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products1 , 2009, The Journal of Immunology.

[16]  Zhang Jinxiang,et al.  Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. , 2009, Biochemical and biophysical research communications.

[17]  F. Gao,et al.  CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury , 2009, Hepatology.

[18]  M. Crow,et al.  Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. , 2009, Kidney international.

[19]  U. Andersson,et al.  The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation , 2009, Journal of leukocyte biology.

[20]  R. Flavell,et al.  Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation , 2009, Nature Immunology.

[21]  J. Emond,et al.  Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. , 2009, Journal of hepatology.

[22]  A. Lentsch,et al.  Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[23]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[24]  Haitao Wen,et al.  TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events , 2008, The Journal of experimental medicine.

[25]  B. Engelhardt,et al.  Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines , 2008, Hepatology.

[26]  Zhigang Tian,et al.  Liver: An organ with predominant innate immunity , 2007, Hepatology.

[27]  F. Gao,et al.  CXCL10 regulates liver innate immune response against ischemia and reperfusion injury , 2007, Hepatology.

[28]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[29]  C. Müller,et al.  CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Provides Myocardial Protection During Cardiac Ischemia/Reperfusion Injury , 2007, Circulation.

[30]  A. Lentsch,et al.  Lymphocyte function during hepatic ischemia/reperfusion injury , 2007, Journal of leukocyte biology.

[31]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[32]  M. Lotze,et al.  Increasing numbers of hepatic dendritic cells promote HMGB1‐mediated ischemia‐reperfusion injury , 2007, Journal of leukocyte biology.

[33]  Courtney M. Lappas,et al.  Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation , 2006, The Journal of experimental medicine.

[34]  F. Krombach,et al.  CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets , 2006, Hepatology.

[35]  M. Lotze,et al.  Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.

[36]  F. Gao,et al.  Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  Ryan M. O’Connell,et al.  Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.

[38]  M. Bilodeau,et al.  Sinusoidal endothelial cell and hepatocyte death following cold ischemia‐warm reperfusion of the rat liver , 2004, Hepatology.

[39]  J. Emond,et al.  Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice , 2004, Hepatology.

[40]  R. Busuttil,et al.  Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.

[41]  F. Sallusto,et al.  Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. , 2003, Pathologie-biologie.

[42]  F. Gao,et al.  Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO‐1 dependence of Stat4 disruption‐mediated cytoprotection , 2003, Hepatology.

[43]  A. Lentsch,et al.  Endogenous IL‐13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury , 2003, Hepatology.

[44]  A. Lentsch,et al.  Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6 , 2000, Inflammation Research.

[45]  M. Miyazaki,et al.  IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. , 1999, The American journal of pathology.

[46]  J. M. Henderson,et al.  Liver transplantation and rejection: an overview. , 1999, Hepato-gastroenterology.

[47]  G. Gerken,et al.  Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. , 1995, Journal of hepatology.

[48]  M. Shimada,et al.  Ischemic injury in liver transplantation: Difference in injury sites between warm and cold ischemia in rats , 1992, Hepatology.

[49]  J. Cofer,et al.  The influence of preservation injury on rejection in the hepatic transplant recipient. , 1990, Transplantation.